NUVB

Conviction 77HealthcareScan · Fri, Jun 26, 2026

NUVB$5.61-3.53%

ResistanceSupportVol 14Insider sell

Vol MA14 9.15M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Nuvation Bio Inc.PHARMACEUTICAL PREPARATIONSwww.nuvationbio.com ↗

Price5.61

Change-3.53%

Gap-0.17%

Rel volume6.62×

Avg volume7.8M

Avg $ vol42.2M

SMA 205.21

SMA 504.91

SMA 2005.38

Price vs 50+14.07%

Price vs 200+4.11%

MA stackmixed

50/200 cross—

Supertrendup · 5.22

RSI (14)57

MACD hist0.09

MACD crossbull · 9d

Stoch %K / %D54 / 70

ADX (14)43

+DI / −DI35 / 14

RSI divergence—

MACD divergence—

ATR %+7.47%

ADR %7.70%

52w high9.54

52w low1.93

From 52w high-41.25%

Above 52w low+190.41%

New 52w highNo

SqueezeOff

Bollinger width37.96%

%B0.70

Donchian pos53.72%

Donchian high6.60

Donchian low4.45

AVWAP (52w high)5.56

vs AVWAP high+0.79%

AVWAP (52w low)4.93

vs AVWAP low+13.77%

OBV trendFlat

Chaikin MF (20)-0.04

Today vs 20d6.62×

Avg vol (14d)9.15M

Avg vol (20d)7.8M

Avg $ vol (20d)42.2M

Market cap—

RS 3m (vs SPY)+20.85%

RS 6m (vs SPY)-46.32%

RS line new highNo

Trend template5/8

Technical rank50.5

1 week+0.81%

1 month+18.25%

3 months+26.81%

6 months-39.99%

1 year+198.14%

YTD-34.67%

P/E-9.89

P/B6.33

P/S32.16

P/FCF—

EPS-0.6000

Div yield—

ROE-64.03%

ROA-33.53%

Debt/Eq0.17

Current7.44

EV/EBITDA-9.23

Gross margin1.26%

Net margin-325.31%

Rev growth698.96%

EPS growth63.97%

Price target14.40

Target upside147.85%

Analyst ratingBuy

Institutional67.92%

Ent. value1.95B

Revenue83.23M

Net income5.4M

Gross profit9.77M

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out348.2M

Employees307

ListedWed, Feb 10, 2021

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeA

Conviction77 / 100

Pattern quality—

Tech rank50.5 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance6.12

Support4.10

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in NUVB

All disclosures →

No recent disclosed trades by Congress in NUVB. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in NUVB · 8 buys · 2 sells

Insider	Side	Shares	Value	Traded	Filed
BLICKENSTAFF KIM D Director · Stock Option (Right to Buy) · 2026-05-21	Grant	123.4K	$0	2026-05-21	2026-05-26
Mashal Robert Director · Stock Option (Right to Buy) · 2026-05-21	Grant	123.4K	$0	2026-05-21	2026-05-26
VERNON W ANTHONY Director · Stock Option (Right to Buy) · 2026-05-21	Grant	123.4K	$0	2026-05-21	2026-05-26
Bazemore Robert B Director · Stock Option (Right to Buy) · 2026-05-21	Grant	123.4K	$0	2026-05-21	2026-05-26
Cui Xiangmin Director · Stock Option (Right to Buy) · 2026-05-21	Grant	123.4K	$0	2026-05-21	2026-05-26
FALBERG KATHRYN E Director · Stock Option (Right to Buy) · 2026-05-21	Grant	123.4K	$0	2026-05-21	2026-05-26
Cui Xiangmin Director · Stock Option (Right to Buy) · 2026-02-27	Grant	76.92K	$0	2026-02-27	2026-05-26
Liu Dongfang CHIEF MEDICAL OFFICER · Class A Common Stock · 2026-04-17	Exercise	50K	$97K	2026-04-17	2026-04-21
Wentworth Kerry CHIEF REGULATORY OFFICER · Stock Option (Right to Buy) · 2026-04-17	Exercise	36.75K	$0	2026-04-17	2026-04-21
Wentworth Kerry CHIEF REGULATORY OFFICER · Class A Common Stock · 2026-04-17	Sell	36.75K	$184K	2026-04-17	2026-04-21

SEC filings

EDGAR filings in NUVB · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.